Friday - March 20, 2026

Category Archives: Professional Services

Projecting the Global Neuromodulation Devices Market Size to Expand at a 9.44% CAGR Through 2032, DelveInsight Analysis

Neuromodulation Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The neuromodulation devices market is experiencing rapid growth, … Continue reading →

Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals

The Key Amyotrophic Lateral Sclerosis Companies in the market include – Amylyx Pharmaceuticals, Sanofi, Brainstorm Cell Therapeutics, AI Therapeutics, Ionis, Biogen, Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, Alector, GSK, NeuroSense Therapeutics, Biogen, Ionis Pharmaceuticals, Brainstorm Cell Therapeutics, Cytokinetics, Astellas Pharma, … Continue reading →

Neighborly Roofing Co. Shares Seasonal Roofing Tips for Palm Harbor Homeowners Transitioning from Winter to Spring

Neighborly Roofing Co. has released a homeowner guide to help Palm Harbor, Florida residents protect their roofs during the seasonal transition from winter to spring. The company highlights how roof installation, roof repair, roof leak repair, and commercial roofing services … Continue reading →

Projecting the Global Neurothrombectomy Devices Market Size to Expand at a 6.88% CAGR Through 2032, DelveInsight Analysis

Neurothrombectomy Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The neurothrombectomy devices market is largely driven by … Continue reading →

Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Complement 3 Glomerulopathy Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | NovelMed Therapeutics, Apellis Pharma, Novartis, Amyndas Pharma

The Key Complement 3 Glomerulopathy Companies in the market include – NovelMed Therapeutics, Apellis Pharmaceuticals, Novartis, Amyndas Pharmaceuticals, and others.   DelveInsight’s “Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Complement 3 … Continue reading →

Diabetic Foot Ulcers Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corp

The Key Diabetic Foot Ulcers Companies in the market include – Amniox (TissueTech), Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corporation, MediWound, Paracrine, INC., NovaLead Pharma, and others.   The Diabetic Foot Ulcers market is expected to … Continue reading →

Advanced Renal Cell Carcinoma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Molecure S.A., Daiichi Sankyo, Janux Therapeutics, NiKang Therapeuti

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →

Myelofibrosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Mye

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myelofibrosis pipeline constitutes 35+ key companies continuously working towards developing 40+ Myelofibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →